Jincheng Wu

Jincheng Wu

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4398145
-
person_outline Jincheng Wu's MOST POPULAR ARTICLES
1-) Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced/metastatic solid tumors or lymphomasF Meric-Bernstam, RF Sweis, FS Hodi, WA Messersmith, RHI Andtbacka, ...Clinical cancer research 28 (4), 677-688, 20221782022
2-) c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologiesJH Bernink, Y Ohne, MBM Teunissen, J Wang, J Wu, L Krabbendam, ...Nature immunology 20 (8), 992-1003, 20191682019
3-) TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblastsAL Grauel, B Nguyen, D Ruddy, T Laszewski, S Schwartz, J Chang, ...Nature communications 11 (1), 6315, 20201242020
4-) Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug–gene co-delivery to cancer cellsCK Chen, WC Law, R Aalinkeel, Y Yu, B Nair, J Wu, S Mahajan, ...Nanoscale 6 (3), 1567-1572, 20141232014
5-) Oxygen transport and stem cell aggregation in stirred-suspension bioreactor culturesJ Wu, MR Rostami, DP Cadavid Olaya, ES TzanakakisPLoS One 9 (7), e102486, 20141162014